eIF2α kinase 2 bridges YTHDF3 and eIF3a to recognize the 5′UTR of m6A-methylated RNA and enhances YTHDF3/eIF3a complex stability in oxaliplatin-resistant CRC cells [267]. Here, EIF3A is linked to colorectal carcinoma.